- Current report filing (8-K)
November 23 2010 - 11:03AM
Edgar (US Regulatory)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Date of Report (Date of earliest event reported): November 23, 2010
MEDCATH CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
(State or other
jurisdiction of incorporation or organization)
|
|
000-33009
(Commission File Number)
|
|
56-2248952
(IRS Employer Identification No.)
|
10720 Sikes Place
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)
(704) 815-7700
(Registrants telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
|
|
|
o
|
|
Written communications pursuant to Rule 425 under the Securities
o
Act (17 CFR 230.425)
|
|
|
|
o
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
o
(17 CFR 240.14a-12)
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under
o
the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
o
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under
o
the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
|
Item 2.02.
|
|
Results of Operations and Financial Condition
|
On November 23, 2010, MedCath Corporation issued a press release announcing an update to the
strategic alternatives process and its results of operations for the fiscal quarter and year ended
September 30, 2010. A copy of the press release and supplemental financial information are
furnished as Exhibits 99.1 and 99.2, respectively.
|
|
|
Item 9.01.
|
|
Financial Statements and Exhibits
|
Exhibit 99.1 Press Release dated November 23, 2010
Exhibit 99.2 Supplemental Financial Information
Exhibits 99.1 and 99.2 listed in this Item 9.01 are being furnished under Item 2.02 and shall not
be deemed filed for purpose of Section 18 of the Securities Exchange Act of 1934, as amended, nor
shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as
amended, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
MEDCATH CORPORATION
|
|
Date: November 23, 2010
|
By:
|
/s/ James A. Parker
|
|
|
|
James A. Parker
|
|
|
|
Executive Vice President and Chief
Financial Officer
|
|
|
INDEX TO EXHIBITS
|
|
|
Exhibit No.
|
|
Description
|
Exhibit 99.1
|
|
Press Release dated November 23, 2010
|
Exhibit 99.2
|
|
Supplemental Financial Information
|
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medcath (NASDAQ:MDTH)
Historical Stock Chart
From Jul 2023 to Jul 2024